Product news

Share this article:

Quinnova Pharmaceuticals announced the commercial launch of Tersi Foam, (2.25% selenium sulfide) for the treatment of seborrheic dermatitis and tinea versicolor of the skin.

TopoTarget has announced that its Totect chemotherapy treatment has been approved by the FDA for marketing in the US. In October 2006, Totect was launched in Europe under the Savene brand. Totect is used as a therapy when anthracycline, intravenously administered, accidentally leaks into the surrounding healthy tissue. Anthracyclines are chemotherapeutic agents used to treat a large number of cancers including breast cancer and leukaemia.

The FDA has approved Ranbaxy Pharmaceuticals' version of carvedilol tablets, a beta blocker used to treat mild to severe heart failure. Total annual sales of the brand name equivalent of the drug, Coreg by GlaxoSmithKline, were $1.6 billion through June 2007, according to figures from IMS.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.